The immunodepressive activity of N-diazoacetylglycine derivatives in mice. 1973

G Brambilla, and M Cavanna, and A Maura, and S Parodi, and A Furlani, and V Scarcia, and R Della Loggia

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester

Related Publications

G Brambilla, and M Cavanna, and A Maura, and S Parodi, and A Furlani, and V Scarcia, and R Della Loggia
April 1979, European journal of cancer,
G Brambilla, and M Cavanna, and A Maura, and S Parodi, and A Furlani, and V Scarcia, and R Della Loggia
November 1974, Antimicrobial agents and chemotherapy,
G Brambilla, and M Cavanna, and A Maura, and S Parodi, and A Furlani, and V Scarcia, and R Della Loggia
May 1976, Experientia,
G Brambilla, and M Cavanna, and A Maura, and S Parodi, and A Furlani, and V Scarcia, and R Della Loggia
January 1974, Bollettino dell'Istituto sieroterapico milanese,
G Brambilla, and M Cavanna, and A Maura, and S Parodi, and A Furlani, and V Scarcia, and R Della Loggia
January 1979, Drug and chemical toxicology,
G Brambilla, and M Cavanna, and A Maura, and S Parodi, and A Furlani, and V Scarcia, and R Della Loggia
August 1980, Mutation research,
G Brambilla, and M Cavanna, and A Maura, and S Parodi, and A Furlani, and V Scarcia, and R Della Loggia
January 1979, Advances in experimental medicine and biology,
G Brambilla, and M Cavanna, and A Maura, and S Parodi, and A Furlani, and V Scarcia, and R Della Loggia
January 1975, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
G Brambilla, and M Cavanna, and A Maura, and S Parodi, and A Furlani, and V Scarcia, and R Della Loggia
January 2023, Recent advances in inflammation & allergy drug discovery,
G Brambilla, and M Cavanna, and A Maura, and S Parodi, and A Furlani, and V Scarcia, and R Della Loggia
July 1979, Antibiotiki,
Copied contents to your clipboard!